Call
+918447748545

Published on: Jan 02, 2021
2 minute read
By: Dr Rajan Choudhary

COVID-19 Variant: What We Know About This New Mutation

COVID-19 Variant: What we know about this new mutation

In early December a new variant of COVID -19 was detected in the UK, raising concerns across the world. SARS-CoV-2 has already significantly impacted the world, with 84 million cases worldwide and nearly 2 million deaths. Could the new variant cause further havoc? Is it something we should be worried about? Today we will have a look at what we know so far about the virus.

MUTAGENESIS

To start with we should go over viral mutations. Unlike complex organisms, viruses are highly prone to genetic mutations, even more than bacteria. All organisms including humans, birds, even worms, are prone to mutations as well. However due to their complexity, there is much higher risk of mutations causing significant problems with their cellular and genetic processes, problems that are often incompatible with life, or lead to cancer. For this reason, there are significant genetic roadblocks present to prevent such mutations from occurring.

Viruses on the other hand have genetic replication machinery of poor “quality”, prone to introducing mutations. Since they replicate quickly, with little care on which viral particles survive, it matters little if hundreds of viruses do not survive, as further thousands will and continue to spread in their host. It is for this reason we have such difficulty treating viruses or making viruses against them .

COVID VARIANT

The variant was first picked up by the COVID-19 Genomics UK consortium, which undertakes random genetic sequencing of positive COVID-19 samples across the UK. Since April they have sequenced 140,000 virus genomes, to identify and track outbreaks across the UK. The strain was first identified in September and sequenced in early October. However, the significance of this strain was not realized until the end of the year. By 13th December 1108 cases had been identified across 60 different locations, though the true number is likely much higher. In Norfolk, it accounts for nearly 20% of all samples.

17 Variations have been identified, most significantly in the spike protein the virus uses to bind to the ACE2 receptor found in the lungs. Changes in this protein may have resulted in it being more infectious and spreading more quickly between people. A review of current evidence has shown the rate of transmission was 71% higher than the other variants and may also have a much higher viral load. This has given it an advantage over the other COVID-19 strains- it has already been detected in South Africa, Europe, and America, and it is likely to become the dominant global strain in the near future.

It appears children are more susceptible to catching this virus. The virus propagated at a time when schools were open and running, whilst the rest of the country remained in lockdown. This may have provided a larger pool of children for the virus to spread in, resulting in this change. However, this does not mean that the virus “attacks” children, rather it is able to attach to ACE2 receptors in children’s lungs with greater ease and spread quickly.

VACCINE

The most important question on everyone’s mind – will the vaccine be effective against this new strain? If not, lockdown rules may be extended until new vaccines are discovered, and by then newer strains may leapfrog ahead and make the new vaccines irrelevant again.

So far experts believe that the new variant is unlikely to make vaccines ineffective. The vaccines all produce antibodies against the viral spike protein, but so far it appears the mutation has not changed the shape or function of the spike protein enough for antibodies to fail against it. The antibodies should be able to recognize enough sites on the spike protein to successfully attach, neuter the protein, and present the virus for destruction by the body’s immune system. Unfortunately, it will take some time to fully understand the effects of the mutation, though we can remain hopeful for now

www.secondmedic.com

Read Blog

AI-Based Disease Detection India: How SecondMedic Is Transforming Early Diagnosis

India’s healthcare landscape is evolving rapidly, with artificial intelligence emerging as one of the most powerful tools for early disease detection. AI-based disease detection India represents a major shift from reactive healthcare to predictive, preventive, and precise medical analysis. Instead of waiting for symptoms to appear, AI enables clinicians and patients to identify risks early through advanced data interpretation.

Rising chronic diseases, increased diagnostic loads, and limited specialist availability make AI essential for early diagnosis in India. The use of AI in medical imaging, risk scoring, and pattern recognition significantly enhances accuracy while reducing time-consuming manual processes. SecondMedic integrates AI-powered diagnostic tools to help individuals detect health conditions in their earliest stages, enabling timely intervention and improved long-term outcomes.

Why India Needs AI-Based Disease Detection

India faces one of the world’s highest burdens of chronic and lifestyle diseases. Many conditions remain undiagnosed until they reach advanced stages, often due to late screenings, limited access to specialists, or lack of early symptoms.

The need for AI-based detection is driven by:

High incidence of silent diseases like diabetes and hypertension
Overloaded healthcare systems
Limited availability of expert radiologists
Rising lifestyle risk factors
Increasing demand for precision diagnostics
Need for faster, more accurate analysis

AI bridges these gaps by providing early alerts, consistent accuracy, and fast interpretations.

How AI Detects Diseases Early

AI-based disease detection uses machine learning models trained on thousands of medical datasets. These models learn to recognize abnormal patterns and subtle changes that the human eye might overlook.

AI analyzes:

Blood test patterns
Vital signs and wearable data
Imaging scans (X-rays, MRIs, CT scans)
Medical history
Genetic predispositions
Lifestyle habits

Through advanced algorithms, AI can identify risks long before symptoms appear, giving patients critical time for prevention and treatment.

AI in Medical Imaging: A Major Breakthrough for India

Medical imaging AI has transformed diagnosis speed and accuracy. In India, where access to radiologists is uneven, AI helps bridge diagnostic gaps.

AI-assisted imaging helps detect:

Lung infections and tuberculosis
Early-stage cancer indicators
Cardiac abnormalities
Brain tumors and neurological issues
Bone fractures and musculoskeletal conditions
Liver and kidney anomalies

SecondMedic uses AI-supported imaging interpretation to enhance precision and reduce reporting delays.

AI for Chronic Disease Prediction

Chronic illnesses often develop silently. By analyzing long-term trends, AI can predict disease progression and alert patients earlier.

AI helps forecast:

Prediabetes to diabetes progression
Heart attack risk
Hypertension development
Chronic kidney disease
Thyroid dysfunction
Metabolic health decline

These predictions allow individuals to take preventive action far in advance.

Personalized Disease Detection with AI

AI enables personalized diagnostics by incorporating each user’s biological and lifestyle data into prediction models.

Personalized AI detection considers:

Age and family history
Diet and activity levels
Sleep patterns
Stress levels
Blood markers
Genetic factors

This creates a highly individualized health risk profile.

SecondMedic’s AI engine creates a personalized risk score for each user, allowing targeted preventive strategies.

AI for Cancer Early Detection

Cancer often goes undiagnosed until it reaches advanced stages. AI helps detect early warning signs by analyzing subtle abnormalities.

AI supports early cancer detection in:

Breast cancer (mammograms)
Cervical cancer (Pap tests and visual scans)
Lung cancer (X-rays and CT scans)
Colon cancer indicators
Skin cancer lesion analysis

This improves survival rates by supporting early diagnosis.

Real-Time Monitoring with AI

Continuous monitoring is essential for early disease detection. AI integrates with wearable devices and digital health tools to track vital parameters in real time.

AI monitors:

Heart rate trends
Oxygen levels
Blood pressure variations
Stress levels
Sleep quality
Blood glucose fluctuations (connected devices)

Real-time alerts notify users of abnormalities that require attention.

AI in Public Health Disease Detection

AI is also used at the population level to identify disease patterns and outbreaks.

AI supports public health by:

Predicting outbreak patterns
Analyzing environmental health impact
Tracking regional disease trends
Supporting government screening programs

This strengthens India’s preventive health strategy.

How SecondMedic Uses AI for Disease Detection

SecondMedic integrates AI tools throughout its digital healthcare ecosystem, helping individuals access early detection and preventive insights.

SecondMedic’s AI capabilities include:

Risk scoring for diseases
AI analysis of medical reports
Predictive analytics dashboards
Early-warning alerts
Integration with wearables
AI-supported doctor consultations

This helps users understand risks clearly and take action early.

Challenges in AI-Based Disease Detection

While AI offers powerful benefits, it must be used responsibly.

Challenges include:

Requirement of high-quality medical data
Need for clinical validation
Maintaining data privacy
Avoiding algorithmic bias
Ensuring user awareness and understanding

SecondMedic follows ethical AI practices aligned with DPDP Act and ABDM standards.

Future of AI-Based Disease Detection in India

AI will continue to redefine diagnostics in India over the next decade.

Future developments include:

Deep AI for full-body scan interpretation
Genomic-based AI predictions
Emotion and mental health detection through AI
AI-assisted virtual triage systems
At-home AI diagnostic kits
National integrated AI health platforms

SecondMedic aims to lead in these innovations by integrating advanced predictive tools.

Conclusion

AI-based disease detection India is shaping a new era of proactive healthcare. By analyzing health patterns, detecting abnormalities early, and providing accurate risk assessment, AI empowers individuals to act before diseases progress. SecondMedic uses AI-driven diagnostic tools to support early detection, preventive care, and long-term health protection.

To explore AI-powered diagnostic support, visit www.secondmedic.com

References

NITI Aayog – AI for Healthcare in India
WHO – AI in Early Disease Detection
ICMR – Chronic Disease Patterns India
IMARC – Indian AI Healthcare Market
FICCI – AI and Precision Medicine India

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.